Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322852 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100320417 Thermal nanocomposites
12/23/2010CA2803059A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
12/23/2010CA2801729A1 Compositions for and methods of activating guanylyl cyclase c
12/23/2010CA2767163A1 Dendrimer based nanodevices for therapeutic and imaging purposes
12/23/2010CA2765792A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
12/23/2010CA2765541A1 Nanodispersion of a drug and process for its preparation
12/23/2010CA2765522A1 Solid pharmaceutical composition of edoxaban having improved solubility
12/23/2010CA2765448A1 Stimulation of innate immunity with an antigen from bacterial origin
12/23/2010CA2765413A1 Dosage forms of apixaban
12/23/2010CA2764881A1 Solid forms for tissue repair
12/23/2010CA2764832A1 Lipid formulated dsrna targeting the pcsk9 gene
12/23/2010CA2764187A1 Stable nanoparticulate drug suspension
12/23/2010CA2764180A1 Lyophilized formulations for small modular immunopharmaceuticals
12/23/2010CA2763778A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010CA2763695A1 Drug delivery systems
12/23/2010CA2761538A1 Buccal and/or sublingual therapeutic formulation
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264126A2 Drug-delivery vehicles based on reversed liquid crystalline phase materials
12/22/2010EP2264018A2 Thioflavin derivatives for use in the diagnosis of Alzheimer's disease
12/22/2010EP2263788A2 Microcapsules loaded with active ingredients and a method for their preparation
12/22/2010EP2263739A1 Medical system
12/22/2010EP2263738A2 Implantable devices for delivering drugs and other substances to treat sinusitis and other disorders
12/22/2010EP2263719A2 Multireservoir implantable drug delivery pumps
12/22/2010EP2263687A1 Immunogenic compositions containing phospholipid
12/22/2010EP2263684A1 IL-21 derivatives
12/22/2010EP2263683A1 Agent for treating skin aging and scars
12/22/2010EP2263680A1 Compressed pharmaceutical compositions comprising PEG and electrolytes
12/22/2010EP2263675A2 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/22/2010EP2263673A1 Opioid formulations having extended controlled release
12/22/2010EP2263671A1 Amide derivative-containing pharmaceutical composition
12/22/2010EP2263662A1 Film-like composition
12/22/2010EP2263661A1 Oral preparation
12/22/2010EP2263660A2 Orally disintegrable tablets
12/22/2010EP2263659A1 Contraceptive comprising folic acid
12/22/2010EP2263658A1 Controlled release hydrocodone formulations
12/22/2010EP2263657A1 Controlled release lamotrigine formulations
12/22/2010EP2263656A1 Delayed release pharmaceutical formulations
12/22/2010EP2263655A1 Pharmaceutical formulation comprising atorvastatin calcium
12/22/2010EP2263654A1 Compositions and methods to improve the oral absorption of antimicrobial agents
12/22/2010EP2263653A2 Preparation of lipid based nano-particles with a dual asymetric centrifuge
12/22/2010EP2263652A1 Aerosols comprising nanoparticle drugs
12/22/2010EP2263651A2 Low viscosity liquid dosage forms
12/22/2010EP2263650A2 Nanoparticulate megestrol formulations
12/22/2010EP2263649A1 Pharmacological adjuvants based on coordination compounds of d-metals
12/22/2010EP2263648A1 Ophthalmic composition
12/22/2010EP2263637A1 Medicinal preparation for oral administration
12/22/2010EP2263596A1 Dispensing apparatus and cartridge
12/22/2010EP2262857A1 Thermoplastic starch compounds
12/22/2010EP2262758A2 O-desmethylvenlafaxine salts
12/22/2010EP2262536A2 Stabilizing lipid compositions for oral pharmaceutical agents
12/22/2010EP2262534A1 Palatable solid composition comprising antacid and saliva stimulant
12/22/2010EP2262521A1 Ophthalmic compositions comprising a dipeptide
12/22/2010EP2262515A2 Use of black soybean for treating ophthalmic diseases
12/22/2010EP2262506A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
12/22/2010EP2262490A1 Transdermal therapeutic system having stabilized membrane
12/22/2010EP2262489A2 Hollow nanoparticles and uses thereof
12/22/2010EP2262488A1 Colchicine solid complex; methods of making; and methods of use thereof
12/22/2010EP2262487A2 An orally disintegrating tablet of cilostazol
12/22/2010EP2262486A1 Quetiapine composition
12/22/2010EP2262485A1 Modified release composition comprising doxofylline
12/22/2010EP2262484A1 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
12/22/2010EP2262483A2 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
12/22/2010EP2262482A1 Controlled release drug delivery systems and pharmaceutical compositions formed therewith
12/22/2010EP2262481A2 Bupivacaine formulation in a polyorthoester carrier
12/22/2010EP2262480A1 Immunomodulator particles and methods of treating
12/22/2010EP2262479A2 Amorphous arformoterol l-(+)-tartrate
12/22/2010EP2262478A2 Activated nitric oxide donors and methods of making and using thereof
12/22/2010EP2262477A1 Process for preparing concentrated aqueous micellar solutions
12/22/2010EP2262476A1 Drug delivery to the anterior and posterior segments of the eye using eye drops.
12/22/2010EP2262475A1 Chewable tablet and method of formulating
12/22/2010EP2262474A2 Methods and compositions for wound healing
12/22/2010EP2262369A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
12/22/2010EP2073791B1 Capecitabine pediatric tablets
12/22/2010EP2007367B1 Medicated feed premix comprising chlortetracycline hydrochloride
12/22/2010EP1883392B1 Process for preparation of isotonic aqueous injection of ropivacaine
12/22/2010EP1845957B1 Method for producing a drug extract that contains hydroxystilbenes
12/22/2010EP1740166B1 Therapeutic antimicrobial compositions and methods
12/22/2010EP1682097B1 Non-tabletted, chewable, individually dosed administration forms
12/22/2010EP1536843B1 Radiolabeled compounds and liposomes and their methods of making and using the same
12/22/2010EP1390037B1 Use of glucocorticoid receptor-specific antagonists for the treatment of delirium
12/22/2010EP1364660B1 Drug-releasing system of biodegradable polymer type
12/22/2010EP1323416B1 Process for producing medicinal solid dispersion
12/22/2010EP1214064B1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
12/22/2010EP0708805B2 Seals for use in an aerosol delivery device
12/22/2010CN201676085U Self-heating indomethacin patch
12/22/2010CN1994366B Chinese medicinal formulation for treating gynecological disease and preparation process thereof
12/22/2010CN1990045B Highly effective plaster for burn and scald and its preparation process
12/22/2010CN1943737B A Chinese traditional medicinal composition used for treatment of nephritis and its preparation method
12/22/2010CN1915401B Composition of Chinese traditional medicine for treating phthisis, and application
12/22/2010CN1835722B Transdermal hormone delivery system: compositions and methods
12/22/2010CN1826100B Controlled release preparation
12/22/2010CN1824075B Medicinal composition for treating hemicrania and its application
12/22/2010CN1806823B Externally applied wind-expelling Chinese medicinal composition plaster
12/22/2010CN1626133B Medication for treating coronary heart disease
12/22/2010CN101925358A Chlorine dioxide liquid preparation composition
12/22/2010CN101925356A Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation
12/22/2010CN101925355A Fentanyl-containing patch for external use
12/22/2010CN101925350A Anti - retroviral combination
1 ... 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 ... 2991